SYMPHONY LIMITED
SYMPHONY · General/Diversified · NSE
₹807
Current Market Price
Fair Value (DCF)
₹893
Margin of Safety
+10.6%
Updated 1d ago
YieldIQ Score
74/100
Piotroski F-Score
8/9
Economic Moat
Wide
Confidence
65%
ROE
—
Debt/Equity
0.01
WACC
11.1%
Market Cap
₹5,540 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
36.6%
Return on capital employed
EV / EBITDA
27.8×
Enterprise multiple
Debt / EBITDA
0.8×
Leverage vs earnings
Interest Coverage
29.4×
EBIT covers interest
Current Ratio
1.24×
Short-term liquidity
Asset Turnover
1.18×
Revenue per ₹ of assets
Revenue CAGR (3Y)
15.0%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹806.75
Bear case
₹480.49
MoS -67.9%
Base case
₹892.63
MoS +9.6%
Bull case
₹1,024.28
MoS +21.2%
Ratio Trends
SYMPHONY · last 8 annual periods
ROE
27.9%
ROCE
34.5%
Operating Margin
—
Debt / Equity
0.19×
PE
162.0×
EV / EBITDA
36.8×
Historical Financials
SYMPHONY · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹900 Cr | ₹641 Cr | ₹239 Cr | ₹332 Cr | ₹1573 Cr | +15.0% |
| EBITDA | — | ₹201 Cr | ₹189 Cr | ₹217 Cr | ₹312 Cr | +11.6% |
| EBIT | ₹142 Cr | ₹147 Cr | ₹57.0 Cr | ₹60.0 Cr | — | -19.4% |
| PAT | ₹107 Cr | ₹111 Cr | ₹43.0 Cr | ₹48.0 Cr | ₹213 Cr | +18.7% |
| EPS (diluted) | ₹15.35 | ₹15.84 | ₹6.17 | ₹7.02 | — | -17.8% |
| CFO | ₹89.0 Cr | ₹8.0 Cr | ₹136 Cr | ₹161 Cr | ₹259 Cr | +30.6% |
| CapEx | — | — | — | — | ₹-23.2 Cr | — |
| FCF | — | — | — | — | ₹236 Cr | +0.0% |
| Total Assets | — | ₹1367 Cr | ₹1099 Cr | ₹1218 Cr | ₹1334 Cr | -0.6% |
| Total Debt | — | — | ₹22.0 Cr | ₹93.0 Cr | ₹142 Cr | +59.3% |
| Shareholders' Equity | — | — | ₹912 Cr | ₹749 Cr | ₹761 Cr | -4.4% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
SYMPHONY vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| GREENLAM GREENLAM | — | — | Pending | 6.2% | — |
| SFL SFL | — | — | Pending | 3.1% | — |
| TTKPRESTIG TTKPRESTIG | — | — | Pending | 6.0% | — |
| EUREKAFORB EUREKAFORB | — | — | Pending | 3.7% | — |
| CELLO CELLO | — | — | Pending | 14.1% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for SYMPHONY in the last 10 years.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. SYMPHONY LIMITED (SYMPHONY.NS) trades at 806.75 vs a model fair value of 892.63, a gap of 10.6%. Piotroski F-score: 8/9. Moat label: Wide...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of SYMPHONY →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for SYMPHONY →
Compare
Head-to-head with peers
Compare SYMPHONY side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse SYMPHONYNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.